Author

Лобовикова Оксана Анатольевна

Observed names: O A Lobovikova, O. A. Lobovikova, O.A. Lobovikova, Лобовикова О. А., Лобовикова О.А., Лобовикова Оксана Александровна, О А Лобовикова, О. A. Lobovikova, О. А. Лобовикова, О. Лобовикова, О.А. Лобовикова

Institutions: Russian Scientific Research Institute Microbe, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

Observed institutions: Russian Scientific Research Institute Microbe, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing

ORCID: 0000-0001-8085-2331

Observed ORCID: 0000-0001-8085-2331

OpenAlex ID: A5024710801

Cultural Antigen in the Technology for Anti-Rabies Immunoglobulin Obtainment from Equine Blood Serum

2012 · S. V. Generalov, E. G. Abramova, et al. · Problems of Particularly Dangerous Infections · 6

Production of Rabbit Anti-Rabies Immunoglobulin Using Cultural Antigen

2012 · S. V. Generalov, E. G. Abramova, et al. · Problems of Particularly Dangerous Infections · 5

Constructing and Medical Trials of a Monoclonal Dot-Immuno-Enzyme Test-System “DIATul-M” for Tularemia Microbe Detection

2013 · N. E. Tereshkina, I. V. Terekhova, et al. · Problems of Particularly Dangerous Infections · 4

Development of an in-house reference standard for anti-rabies immunoglobulin potency, to be used in the virus neutralisation test in a Vero cell culture

2022 · E. G. Abramova, Yu. K. Gavrilova, et al. · Biological Products Prevention Diagnosis Treatment · 3

Methods and Technologies of Cholera Vibrio Cultivation (Scientific Review)

2013 · S. A. Eremin, Yu. A. Aleshina, et al. · Problems of Particularly Dangerous Infections · 3

Enhancement of the Technology for Live Tularemia Vaccine Production

2016 · O. A. Volokh, A. V. Komissarov, et al. · Problems of Particularly Dangerous Infections · 2

Heterologous Anti-Rabies Immunoglobulin - Results of the First Five Years of Production

2010 · E. G. Abramova, A. K. Nikiforov, et al. · Problems of Particularly Dangerous Infections · 2

Current State of Passive Rabies Immunoprophylaxis

2025 · A.A. Savenkova, S.V. Generalov, et al. · Problems of Biological Medical and Pharmaceutical Chemistry · 1

Effectiveness of the “Sterius 60” SHF Radiation Installation for Disinfection of Objects Contaminated with PBA of Groups I–IV, when Working with Infected Biomodels

2021 · V. G. Germanchuk, A. P. Semakova, et al. · Problems of Particularly Dangerous Infections · 1

Review of Post-registration Changes in the Life Cycle of Сholera Bivalent Chemical Vaccine (Review)

2020 · I. V. Shulgina, O. A. Lobovikova, et al. · Drug development & registration · 1

Registration Documentation and Amendments to It as an Element of a Quality Management System in Production of Anti-rabies Immunoglobulin (review)

2019 · O. A. Lobovikova, I. V. Shul'gina, et al. · Drug development & registration · 1

Development of Quality Control Sample to Assess Specific Activity of Anti-rabies Immunoglobulin Obtained From Equine Blood Serum

2019 · E. G. Abramova, O. A. Lobovikova, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1

Construction and Medical Trials of Monoclonal Immuno-Enzyme Test-System for the Detection of Encapsulated Plague Agent Strains, “EIAPESTF1-M”

2016 · Z. L. Devdariani, N. A. Syrova, et al. · Problems of Particularly Dangerous Infections · 1

Deployment of Ultrafiltration for Concentrating and Purification of Antigens

2015 · A. V. Komissarov, Yu. A. Aleshina, et al. · Problems of Particularly Dangerous Infections · 1

Optimization of Specifications for Scaled-Up Fixed Rabies Virus Cultivation (“Moscow 3253” Strain) in Vero Cell Culture

2014 · S. V. Generalov, E. G. Abramova, et al. · Problems of Particularly Dangerous Infections · 1

Optimization of Presentation and Consumer Container of Anti-rabies Immunoglobulin Obtained From Horse Serum

2012 · N. N. Kochkalova, E. G. Abramova, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1

Non-Waste Alternative Technologies in the Production of Heterologous Anti-Rabies Immunoglobulin

2011 · I. M. Zhulidov, E. G. Abramova, et al. · Problems of Particularly Dangerous Infections · 1

Разработка технологии изготовления пептона из фибрина для бактериальных питательных сред

2025 · К. И. Холматов, Н. И. Вахрушина, et al. · Biotekhnologiya

Evaluation of the Molecular Size Distribution of Rabies Immunoglobulin Using High-Performance Liquid Chromatography

2024 · S. V. Generalov, A. A. Savenkova, et al. · Journal Biomed

Оценка Молекулярных Параметров Иммуноглобулина Антирабического Методом Высокоэффективной Жидкостной Хроматографии

2024 · Генералов Сергей Вячеславович, Савенкова Анастасия Александровна, et al. · Journal Biomed

Assessment of Stability of Chemical Cholera Vaccine in a New Primary Packaging

2023 · O. V. Gromova, S. A. Vorob’eva, et al. · Problems of Particularly Dangerous Infections

Разработка алгоритма применения методов in vitro для контроля специфической активности холерного токсина и холерогена-анатоксина в производстве холерной химической вакцины

2023 · О. Дуракова, О. Громова, et al. · Биофармацевтический журнал

Efficiency of Using the Hydrogen Peroxide Vapor Generator “Fhileas 75” for Disinfection of the Air Ducts of separately Ventilated system for Infected Animal Housing

2022 · V. G. Germanchuk, E. V. Kislitsina, et al. · Problems of Particularly Dangerous Infections

Labeling of Immunobiological Drugs, Produced by the Russian Research An-ti-Plague Institution "Microbe" of the Rospotrebnadzor (Review)

2021 · A. V. Komissarov, O. A. Lobovikova, et al. · Drug development & registration

Diagnostic Potential of the Erythrocytic Immunoglobulin Diagnosticum for Indication and Identification of the Causative Agents of Particularly Dangerous (deep) Mycoses

2017 · I. V. Novitskaya, E. V. Prokhvatilova, et al. · Problems of Particularly Dangerous Infections

Works count: 53

Citation count: 35

H-index: 3

I10-index: